PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the treatment of mild cognitive impairment due to Alzheimer’s Disease

Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease.

Similarities Between AI and Psychedelics | Psychedelic Invest

It appears that society is increasingly embracing solutions whose inner workings remain a mystery, a trend underscored by the rising adoption of cutting-edge technologies like

February 15, 2024

Forum Launches with $5M for Virtual Peer Support Groups to Help People Navigate Life’s Challenges

Rajiv Kumar, MD, Co-Founder & CEO (Left) and Lee Pichette Co-Founder, President & COO (Right) What You Should Know: – Forum, a peer support group

November 10, 2023

SGLT-2 Inhibitors Top Other Diabetes Medications for Eye Safety

STOCKHOLM — The sodium glucose co-transporter 2 (SGLT2) class of diabetes medications may offer more protection against diabetic retinopathy as compared with other hypoglycemic agents,

July 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.